Last reviewed · How we verify
NCT05776082
Association of Gestational Cardiovascular Health With Pregnancy Outcomes
trial testing Questionnaire survey and specimen collection in Pregnant Women in 5,000 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | Women's Hospital School Of Medicine Zhejiang University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 1 March 2023 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2027 |
| Sites | 3 locations across China, Rwanda |
Drugs / interventions tested
- Questionnaire survey and specimen collection
Conditions studied
- Pregnant Women — all drugs for Pregnant Women →
Sponsor
Women's Hospital School Of Medicine Zhejiang University
Who can join
Adults 20 to 49, female only, with Pregnant Women. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pregnancy is a critical period for cardiovascular health risk assessment and interventions to reduce the incidence of cardiovascular disease in both mother and child generations. Recently, the American Heart Association proposed the latest cardiovascular health assessment indicator "Life's Essential 8". However, there is still a lack of application data for pregnant women. This project intends to explore the application potential of Life's Essential 8 in cardiovascular health assessment of pregnant women and establish appropriate gestaional cardiovascular health standards.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05776082
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Questionnaire survey and specimen collection
Trials testing the same drug.
- NCT05670548 — Early Prediction of Postpartum Glucose Metabolism Abnormalities in Gestational Diabetes Mellitus · unknown
- NCT05386927 — Early Diagnosis of GDM by Multiomics · unknown
Other recruiting trials for Pregnant Women
Currently open trials in the same condition.
- NCT07238608 — Impact of UFPs and MNPs on Fetal Health · recruiting
- NCT06976632 — Effect of Helfer Skin Tap and Cold Application on Pain and Hemodynamics During Vaccination · NA · recruiting
- NCT07084103 — Effectiveness of a Psychosocial Support Intervention for Women Diagnosed With Fetal Anomaly · NA · recruiting
- NCT07258329 — Screening for Intrapartum Fetal Compromise Using Placental Biomarkers · recruiting
- NCT07058766 — Development of Post-Disaster Care Protocol for Pregnant Women and Evaluation of Its Effectiveness · NA · recruiting
Other Women's Hospital School Of Medicine Zhejiang University trials
Trials by the same sponsor.
- NCT07369986 — Immunotherapy for Surgery Avoidance in Vulnerable dMMR Endometrial Cancer · Phase 2 · not yet recruiting
- NCT07244965 — Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervica · Phase 2 · not yet recruiting
- NCT06561308 — Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer · Phase 2 · recruiting
- NCT07106853 — Prenatal Cell-free DNA Screening in Pregnancies With Diverse Genetic Risk Profiles Utilizing Targeted and Whole-exome Se · not yet recruiting
- NCT07082530 — A RCT of Labor Induction at 39 Weeks in Low - Risk Women in China · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05776082 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Women's Hospital School Of Medicine Zhejiang University
- Last refreshed: 29 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05776082.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing